Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. An Implantable loop recorder (ILR) is a subcutaneous, single-lead, electrocardiographic (ECG) monitoring device used for diagnosis in patients with recurrent unexplained episodes of palpitations or syncope, along with long-term monitoring in patients at risk for or with atrial fibrillation, structural heart disease, bundle branch block, recurrent neurally mediated syncope etc. GlobalData uses proprietary data and analytics to provide a comprehensive report on the implantable loop recorders market in the Netherlands. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the implantable loop recorders market in the Netherlands was Abbott Laboratories followed by Biotronik SE & Co, Boston Scientific and Medtronic.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

An Implantable loop recorder (ILR) consists of the insertable recorder that comes with a battery and two surface electrodes.

The implantable loop recorders market in the Netherlands can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size implantable loop recorders in the Netherlands, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.